Aimei Health Technology Co., Ltd. 8-K

What Happened
Aimei Health Technology Co., Ltd. filed an 8‑K on Feb 13, 2026, reporting it deposited $34,330.96 into its public shareholder trust to extend the company’s SPAC termination date from February 6, 2026 to March 6, 2026. The extension payment triggered the issuance (on Feb 12, 2026) of an unsecured promissory note in the principal amount of $34,330.96 to the company’s Sponsor, Aimei Health Ltd., and United Hydrogen Group Inc.

Key Details

• Extension: one‑month extension of the termination date, from Feb 6, 2026 to Mar 6, 2026; this is the fifteenth extension allowed under the company’s Amended and Restated Articles.
• Extension payment: $34,330.96 deposited into the trust, representing the lesser of $80,000 total or $0.033 per outstanding public share for the month.
• Promissory note: unsecured, no interest, $34,330.96 principal issued Feb 12, 2026; amount split equally between Aimei Health Ltd. and United Hydrogen ($17,165.48 each).
• Conversion right: the payees may convert the note, in whole or in part, into private units at $10.00 per unit (one ordinary share plus a right to receive 1/5 of one ordinary share) immediately prior to the closing of the business combination, with at least two business days’ notice.

Why It Matters
The filing shows the company secured funding to keep its SPAC process alive for another month, giving more time to complete a planned business combination. The promissory note creates an unsecured obligation that will become due when the business combination with United Hydrogen closes, and it carries a conversion feature that could result in additional private units issued to the Sponsor and United Hydrogen (potential dilution). For retail investors, the item signals continued sponsor support but also adds a small secured liability and a potential source of dilution tied to the consummation of the merger.